Novel agents in the treatment of lung cancer: Fourth Cambridge conference Journal Article
| Authors: | Lynch, T. J.; Bonomi, P. D.; Butts, C.; Davies, A. M.; Engelman, J.; Govindan, R.; Herbst, R. S.; Heymach, J. V.; Johnson, B. E.; Martins, R. G.; Perez-Soler, R.; Riely, G. J.; Sandler, A. B.; Sequist, L. V.; Socinski, M. A.; Wong, K. K.; Hart, C. S. |
| Article Title: | Novel agents in the treatment of lung cancer: Fourth Cambridge conference |
| Abstract: | The Fourth Cambridge Conference on Novel Agents in the Treatment of Lung Cancer was held in Cambridge, Massachusetts on September 29 to 30, 2006, to discuss ongoing clinical research of novel targeted agents for the treatment of non - small cell lung cancer, along with supportive basic and translational research into the molecular pathways implicated in cancer growth and resistance. New information, conclusions, and recommendations considered significant for the field by the program faculty are summarized below and presented at greater length in the individual articles and accompanying discussions that comprise the full conference proceedings. © 2007 American Association for Cancer Research. |
| Keywords: | protein kinase b; vasculotropin; cancer chemotherapy; unclassified drug; clinical trial; sorafenib; bevacizumab; cisplatin; erlotinib; raf protein; sunitinib; cancer growth; nonhuman; antineoplastic agents; united states; conference paper; paclitaxel; antineoplastic agent; animals; imatinib; carboplatin; unindexed drug; bortezomib; lung non small cell cancer; lung neoplasms; epidermal growth factor receptor; epidermal growth factor receptor 2; lung cancer; vasculotropin receptor 2; cetuximab; phosphatidylinositol 3 kinase; cancer research; cancer resistance; docetaxel; monoclonal antibody; panitumumab; rash; vandetanib; clinical research; ras protein; k ras protein; pemetrexed; everolimus; mitogen activated protein kinase kinase; basic research; clinical trials; vasculotropin receptor 1; epidermal growth factor receptor kinase inhibitor; paclitaxel poliglumex; matuzumab; stimuvax; 4 (4 fluoro 2 methyl 5 indolyloxy) 6 methoxy 7 [3 (1 pyrrolidinyl)propoxy]quinazoline; canfosfamide; hki 272; lblp 25 |
| Journal Title: | Clinical Cancer Research |
| Volume: | 13 |
| Issue: | 15 |
| ISSN: | 1078-0432 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2007-08-01 |
| Start Page: | 4583s |
| End Page: | 4588s |
| Language: | English |
| DOI: | 10.1158/1078-0432.ccr-07-0716 |
| PUBMED: | 17671145 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 5" - "Export Date: 17 November 2011" - "CODEN: CCREF" - "Source: Scopus" |
